Aspen Neuroscience ASPE
NASDAQ ASPE
$13.82 +1.01 (+7.88%)
At close: Nov 11, 2026 · 4:00 PM EST

Aspen Neuroscience (ASPE) Ending Cash Balance (2024 - 2026)

Analysis

Aspen Neuroscience (ASPE) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Aspen Neuroscience 14.02 Mn -58.36 Mn - 21.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.91 Mn
Dec 31, 2025 82.72 Mn
Dec 31, 2024 15.84 Mn
API Access

Aspen Neuroscience Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ASPE&period=max&api_key=YOUR_API_KEY